A recent study from theInstitute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germanyshows that“MicroRNA-34a regulatescardiacageingand function.”This study was published in the March7 2013NaturebyProf Dimmler, Boon,and others.
On the foundation of this interesting finding,Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD,reports that: Insights into the treatment of alcohol-induced cardiac ageing: Heavy alcohol drinkinginhibits myocardial function and promotes myocardial infarction via up regulation of its targetgene.By limiting the intake of alcohol,one may prevent ageing/stress-associated decline in cardiac function.Together, this studysuggests thatpharmacological formulations encompassing“compounds that inhibit Alcohol-induced target genes”may be used to improve cardiac function in heavy drinkers.
Idea Proposed/Formulated by:Dr L Boominathan Ph.D.
Terms & Conditionsapplyhttp://genomediscovery.org/registration/terms-and-conditions/
Citation:Boominathan,Insights into the treatment of alcohol-induced cardiac ageing: Heavy alcohol drinkinginhibits myocardial function and promotes myocardial infarction via up regulation of its targetgene,23August/2014, 05.44 am,Genome-2-Bio-MedicineDiscovery center(GBMD),http://genomediscovery.org
Courtesy:When you cite drop us a line firstname.lastname@example.org
* Research cooperation
Significance:This study elucidates the mechanism by which Alcohol declines myocardial function. Furthermore, this study suggests, for the first time, small molecule compounds that inhibit Alcohol-induced target gene expression may be used to treat alcoholics suffering from various myocardial disorders, including myocardial infarction.